Pneumococcal antibody protection in patients with autoimmune inflammatory rheumatic diseases with varying vaccination status

Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a Randomized Controlled Trial

(2017) Mai T.T. Nguyen et al.   JOURNAL OF RHEUMATOLOGY

Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)

(2017) MTT Nguyen et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept

(2016) Éva Rákóczi et al.   JOINT BONE SPINE

Longterm Efficacy of an Antipneumococcal Polysaccharide Vaccine among Patients with Autoimmune Inflammatory Rheumatic Diseases

(2016) Adi Broyde et al.   JOURNAL OF RHEUMATOLOGY

Immunosuppressive drugs impairs antibody response of the polysaccharide and conjugated pneumococcal vaccines in patients with Crohn's disease

(2015) Bjørn Kantsø et al.   VACCINE

Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)

(2014) Clifton O Bingham et al.   ANNALS OF THE RHEUMATIC DISEASES

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy

(2013) Shunsuke Mori et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2013) Charlotte Hua et al.   ARTHRITIS CARE & RESEARCH

Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs

(2013) Meliha Crnkic Kapetanovic et al.   ARTHRITIS RESEARCH & THERAPY

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

(2013) Meliha Crnkic Kapetanovic et al.   ARTHRITIS RESEARCH & THERAPY

Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses

(2012) Clare J Wotton et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

(2012) J. Listing et al.   RHEUMATOLOGY

Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate

(2011) E. Coulson et al.   ANNALS OF THE RHEUMATIC DISEASES

Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors

(2011) Meliha Crnkic Kapetanovic et al.   ARTHRITIS AND RHEUMATISM

Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs

(2011) Meliha Crnkic Kapetanovic et al.   CLINICAL RHEUMATOLOGY

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2010) S. van Assen et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

(2009) Clifton O. Bingham et al.   ARTHRITIS AND RHEUMATISM

Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine

(2008) L.B.S. Gelinck et al.   VACCINE